Abstract
ObjectiveTo assess whether the polymyalgia rheumatica (PMR)-like syndrome reported as an immune related adverse event (irAE) from checkpoint inhibitor therapy is consistent with the 2012 European League Against Rheumatism (EULAR)/American...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have